1. Introduction {#sec1}
===============

Acute lung injury (ALI) is associated with significant morbidity and mortality in critically ill patients \[[@B1]--[@B3]\]. Several mechanisms are involved in the development of ALI. The enhanced pulmonary capillary leakage causing pulmonary edema is one of the key factors. Another important mechanism is the formation of atelectases secondary to depletion of surfactant and accumulation of lung tissue fluid \[[@B4]--[@B6]\]. The latter mechanisms in combination with derangement of hypoxic pulmonary vasoconstriction may cause increased venous admixture and progressive deterioration of oxygenation \[[@B4], [@B7], [@B8]\].

The recruitment maneuver (RM) is a widely used technique aiming to reopen atelectatic lung areas in patients with ALI. Transient increase in the airway pressure up to 40--60 cm H~2~O for 40--60 sec reexpands the deaerated lung tissue areas and improves oxygenation \[[@B9]--[@B11]\]. However, the influence of RM on the outcome is controversial \[[@B12], [@B13]\]. Moreover, RM has a number of adverse effects; the most significant of those are barotrauma and cardiovascular collapse \[[@B14]--[@B17]\]. The risks of RM are justified predominantly in potential responders, necessitating a search for tests that can predict the response to the maneuver.

The airway suctioning procedures require deliberate disconnection of airway tubes thereby reducing PEEP to 0 cm H~2~O. This may lead to alveolar derecruitment that produces effects opposite to those of the RM \[[@B18]\]. The most prominent of these effects are reduction of lung compliance and significant decrease in arterial oxygenation. We hypothesized that changes in oxygenation and lung mechanics at the time of derecruitment may be dependent on the antiatelectatic potential related to the response to RM, and thus, prevent its use in potential nonresponders.

Depletion of surfactant is an important factor predisposing to formation of atelectases and alveolar consolidation in patients with ALI. In patients with surfactant deficiency and alveolar instability, RM may be followed by hypoxemia and rapid reconsolidation of lung tissue \[[@B19]\]. Taking this theoretical background into account, the combination of RM and surfactant therapy could be of potential benefit in patients with ALI.

Therefore our study had two goals: (1) to explore whether the efficacy of RM might be predicted on the basis of changes in oxygenation and lung mechanics provoked by the derecruitment maneuver, and (2) to assess the effects of RM combined with endobronchial instillation of surfactant in patients with ALI.

2. Materials and Methods {#sec2}
========================

The study was conducted in compliance with the Helsinki Declaration. The study protocol and the informed consent form were approved by the Ethics Committee of Northern State Medical University, Arkhangelsk, Russian Federation. Written informed consent was obtained from every patient or next of kin.

Thirteen adult patients with ALI requiring mechanical ventilation (MV) were enrolled into the pilot study. All the patients met the ALI criteria of the American-European Consensus Conference \[[@B20]\]. Exclusion criteria were anticipated duration of MV of less than 24 hours, duration of ALI more than 24 hours before the start of study, and inability to perform alveolar recruitment maneuver due to comorbidities. The severity of illness at the entry of study was estimated using SAPS II score. The severity of organ dysfunction and lung injury were assessed at the start of study and at 24 and 48 hrs employing the SOFA score and the lung injury score (LIS), respectively. Patients were sedated with fentanyl (1 mcg/kg/hr) and midazolam (0.05 mg/kg/hr) and ventilated using pressure-controlled ventilation (Avea, VIASYS Heathcare, USA) with the following baseline ventilator settings: tidal volume 7 mL/kg of predicted body weight, FiO~2~ 0.5, and PEEP 4 cm H~2~O. The respiratory rate was adjusted to maintain PaCO~2~ of 35--45 mm Hg. If these settings did not result in a SaO~2~ ≥ 92%, FiO~2~ was increased by steps of 0.1 every two minutes up to 0.8.

We recorded parameters of mechanical ventilation including tidal volume (*V* ~*T*~), inspiratory oxygen fraction (FiO~2~), peak airway pressure (*P* ~peak~), mean airway pressure (*P* ~mean~), positive end-expiratory pressure (PEEP), and respiratory compliance (*C*). In parallel, we analyzed arterial blood gases including pH, PaCO~2~, PaO~2~, SaO~2~, base excess (BE), and lactate concentration. The end-tidal CO~2~ (EtCO~2~) was registered using Capnostream TM monitor (Oridion, Israel).

All the patients were cannulated with a 5 F femoral artery catheter (Pulsiocath PV2015L20, Pulsion) and an 8.5 F jugular central venous catheter (triple-lumen 20 cm catheter). The hemodynamic monitoring was performed using the single transpulmonary thermodilution technique with PiCCO~2~ monitor (Pulsion Medical Systems, Germany). The thermodilution measurements were performed in triplicate with injections of ice-cold (\<8°C) 5% dextrose solution via a central venous catheter. The registered hemodynamic parameters included central venous pressure (CVP), cardiac index (CI), mean arterial pressure (MAP), stroke volume index (SVI), systemic vascular resistance index (SVRI), heart rate (HR), global ejection fraction (GEF), left ventricle contractility index (dPmx), global end-diastolic volume index (GEDVI), and extravascular lung water index (EVLWI) adjusted to predicted body weight (PBW), which was calculated as follows: PBW (kg) = 50 + 2.3 (height (cm)/2.54--60) for male, and PBW (kg) = 45 + 2.3 (height (cm)/2.54--60) for female.

2.1. Recruitment Maneuver {#sec2.1}
-------------------------

After baseline measurements and muscular blockade with pipecuronium (0.06 mg/kg), RM was performed by applying a continuous positive airway pressure of 40 cm H~2~O for a period of 40 seconds \[[@B9], [@B21]\]. The recruitment maneuver was discontinued in case of hypotension (MAP \< 50 mm Hg, or a decrease in MAP by more than by 30 mm Hg from the initial value), or hypoxemia (SpO~2~ \< 85% or a decrease by more than 10%). Then, pressure-controlled ventilation was resumed with the same settings as before RM. The level of PEEP was set at 2 cm H~2~O above the lower inflection point (LIP) of the pressure-volume (*P*-*V*) curve determined by an inflection point maneuver of the ventilator, but not less than 4 cm H~2~O.

The arterial blood gases, SpO~2~, *V* ~*T*~, and EtCO~2~ were registered at 5 min after the RM. The efficacy of the RM was assessed by detecting the changes in SpO~2~ and *V* ~*T*~. Patients were defined as responders if the absolute SpO~2~ value increased by at least 2% or *V* ~*T*~ rose by at least 10% \[[@B10]\]. The stability of the RM was assessed by registering the changes in SpO~2~, *V* ~*T*~, and EtCO~2~ at 5 min intervals during the subsequent 30 min period. The RM was considered as stable if the absolute value of SpO~2~ decreased by ≤2% or *V* ~*T*~ decreased by ≤5%.

2.2. Derecruitment Test {#sec2.2}
-----------------------

After the assessment of RM stability, the derecruitment test was performed. Positive end-expiratory pressure was set at 0 cm H~2~O for a period of 15 minutes. Other parameters of mechanical ventilation were unchanged. The changes in SpO~2~, *V* ~*T*~, and EtCO~2~ were registered every five minutes. At the end of the derecruitment test, we analyzed the arterial blood gases. The derecruitment test was interrupted in case of severe hypoxia (SpO~2~ \< 85%). The test was defined as positive if it resulted in a decrease in SpO~2~ by at least 2% and in *V* ~*T*~ by at least 10%, respectively.

2.3. Surfactant Therapy {#sec2.3}
-----------------------

After the derecruitment test, PEEP was adjusted to the previous value. The patients were randomized, by means of the sealed envelope method, to a surfactant therapy group (ST group, *n* = 6), and a conventional therapy group (CT group, *n* = 7). Physicians and research staff were not blinded to the study groups. The ST group received the surfactant emulsion (Surfactant-BL, Biosurf, Russia) prepared *ex tempore* and administered into the segmental bronchi in a total dose of 6.0 mg/kg of PBW (0.4 mL/kg of PBW) by means of fiberoptic bronchoscopy (FOB) according to the recommendations of the manufacturer. The CT group received an equivalent volume of 0.9% NaCl endobronchially. After FOB and instillation of surfactant emulsion or 0.9% NaCl, the RM was repeated followed by adjustment of PEEP. The FOB with instillation of the study medicine was repeated at 18 hrs and 32 hrs.

Arterial blood gases and parameters of hemodynamics and mechanical ventilation were registered at 1, 2, 4, 8, 16, 24, 32, and 48 hrs after the initial instillation of surfactant emulsion or 0.9% NaCl.

2.4. Statistical Analysis {#sec2.4}
-------------------------

For data collection and analysis we used SPSS software (version 18.0; SPSS Inc, Chicago, IL). The data distribution was assessed with Shapiro-Wilk test. Quantitative data were presented as mean ± standard deviation or median (25th--75th percentile) depending on the data distribution. The discrete data were expressed as absolute values or percentages. In case of normal distribution, we used Student\'s *t*-test for comparisons between groups. Nonparametrically distributed data were assessed by the Mann-Whitney *U*-test. The correlation analysis was performed using Pearson\'s or Spearman\'s tests for parametrically and nonparametrically distributed data, respectively. The discrete data were evaluated using chi-square test. For all tests, a *P* value \< 0.05 was considered as significant.

3. Results {#sec3}
==========

The individual demographic and clinical characteristics of the patients are presented in [Table 1](#tab1){ref-type="table"}. At the study entry, patients had a mean SAPS II score of 40 ± 13 points and a mean SOFA score of 8.7 ± 3.0 points. During the study, the severity of organ dysfunction decreased slightly to SOFA score of 7.4 ± 3.3 at 48 hrs. Initially, the patients had severe lung injury accompanied by a LIS of 2.5 ± 0.7 points. During the study, LIS did not change significantly. The severity of organ dysfunction and lung injury did not differ between the study groups.

In response to the RM, the changes in SpO~2~ correlated with the changes in PaO~2~ (*r* = 0.79, *P* \< 0.01). As evaluated by the changes in SpO~2~, the RM was successful in 62% of the patients. In parallel, the RM increased the tidal volume significantly (\>10%) in 31% of the patients.

The assessment of the stability of the RM revealed a significant decrease in SpO~2~ among 50% of the responders and a decline in *V* ~*T*~ in 70% of the responders to RM.

The derecruitment test resulted in a decrease in SpO~2~ in 62% of the patients and a reduction of *V* ~*T*~ in 54% of the patients. During the derecruitment test, SpO~2~ decreased in 71% of the responders and 50% of the nonresponders. Most of the patients presented with SpO~2~ ≥ 90%. In three patients, the derecruitment test was interrupted within 5 min due to a rapidly developing hypoxemia. Following derecruitment, a reduction of *V* ~*T*~ was revealed in 100% of the responders to RM and 38% of the nonresponders. We found no correlations between the changes in SpO~2~ and *V* ~*T*~ in response to the RM or to the derecruitment test. The changes in PaO~2~ after RM correlated inversely with changes in *V* ~*T*~ during the derecruitment test (*r* = −0.72, *P* \< 0.05).

We found no significant differences regarding the effects of RM and the derecruitment test in patients with direct and nondirect ALI.

The baseline EVLWI correlated with changes in SpO~2~ during the derecruitment test (*r* = 0.7, *P* \< 0.05), but did not correlate with changes in *V* ~*T*~.

The changes in volumetric parameters, blood gases and lung mechanics are presented in [Table 2](#tab2){ref-type="table"}. After performing the tests and at 16 hrs, PaCO~2~ was significantly higher in the ST group. The surfactant therapy did neither affect PaO~2~/FiO~2~, PaCO~2~, and EtCO~2~, nor minute volume of ventilation, respiratory compliance, selected PEEP values, or FiO~2~. However, the ST group demonstrated a significant increase in EVLWI at 24 and 32 hrs.

4. Discussion {#sec4}
=============

Our study demonstrated no predictive value of the derecruitment test regarding its possibility to uncover effects of RM in patients with ALI. This necessitates a search for alternative predictors of the response to alveolar recruitment. Moreover, the endobronchial instillation of surfactant was not superior to conventional therapy in patients with ALI, and our study revealed that it might even worsen the development of pulmonary edema.

4.1. Recruitment and Derecruitment {#sec4.1}
----------------------------------

The changes in SpO~2~ we noticed during RM correlated with the changes in PaO~2~. This allowed us to assess oxygenation continuously by means of SpO~2~, which is more readily available at the bedside, as compared to frequent blood gases analyses. Identifying responders to RM, we used the cut-off value of SpO~2~ ≥ 2%, which is the average increase in SpO~2~, as demonstrated by *The ARDS Clinical Trials Network* \[[@B10]\]. In contrast to SpO~2~, *V* ~*T*~ increased only in one-third of the patients. Moreover, the recruitment effects were unstable in the majority of patients. These findings may be explained by a prevalence of direct lung injury due to pneumonia (77% of the studied patients) that demonstrate less effective recruitment maneuver and a predisposition to formation of atelectases \[[@B21]--[@B23]\].

The high rate of desaturation and pulmonary recollapse following the derecruitment test reflect changes that can be observed in response to airway disconnection. The lack of a predictive value of the supposed derecruitment test might be explained by the different pattern of changes in ventilation-perfusion interaction during alveolar recruitment and derecruitment \[[@B24], [@B25]\]. However, the inverse correlation between the changes in PaO~2~ after the RM and the changes in *V* ~*T*~ during the derecruitment test demonstrates that patients with lack of improvement of oxygenation during the RM are more predisposed to recollapse of alveoli during the derecruitment. It might be explained by a predominance of the mechanisms of lung consolidation rather than by pulmonary edema in this group of patients. This speculation corresponds to the absence of correlation between changes in *V* ~*T*~ during desaturation and the baseline value of EVLWI. In contrast, the correlation between the baseline EVLWI and the severity of desaturation during the derecruitment test demonstrates a predisposition of patients with lung edema to more severe hypoxemia following derecruitment. These results confirm the potential risk of airway disconnection and should be considered during tracheal suctioning of patients with ALI.

4.2. Surfactant Therapy {#sec4.2}
-----------------------

Our study demonstrated a lack of effect of surfactant therapy in combination with RM in patients with ALI. As evidenced by a recent metaanalysis, these findings are consistent with the results of most of the previous studies in this field \[[@B26]\]. An explanation of the negative result could be that administration of surfactant took place in patients in whom pulmonary edema already had developed, as confirmed by increased EVLWI. We cannot exclude the possibility that alveolar fluid might have inactivated both endogenously produced and exogenously administered surfactant. On the other hand, it could be potentially harmful to restore an assumed lack of surfactant without preassessment of the actual deficit. Therefore, further investigations are required with special focus on the efficacy of surfactant replacement therapy in patients with confirmed surfactant insufficiency.

Although the surfactant treatment used in this study did not influence lung mechanics or alveolar gas exchange, it unexpectedly resulted in enhancement of lung edema. In a recent study by Lu et al. using computed tomography, it has been shown that instillation of exogenous surfactant in patients with ALI/acute respiratory distress syndrome (ARDS) caused substantial expansion of nonaerated lung areas \[[@B27]\]. Several mechanisms might be involved in the progression of lung edema. One of the possible mechanisms is the retention of lung water by hydrophilic components of the surfactant proteins. Another mechanism could be an inflammatory reaction, which is evoked by an interaction between the exogenously administered surfactant and the active endogenous surfactant resulting in capillary leakage and increase in lung edema \[[@B28]\]. Last but not least, improvement of lung tissue aeration and attenuation of pulmonary hypoxic vasoconstriction may extend the contact area between the thermal indicator and the pulmonary vascular bed leading to increase in the measured EVLWI value \[[@B29]\].

Our study has several limitations including a small sample size, heterogeneous patient characteristics, a relatively high prevalence of patients with direct lung injury, and nonblinded treatment with bovine surfactant. The power analysis performed before our study and based on our hypothesis, that surfactant could lead to a 30% increase in PaO~2~/FiO~2~ with no changes in PaO~2~/FiO~2~ in the CT group, revealed that assuming a two-sided *P* value of 0.05 and 80% power, a sample size of 18 patients in each group is required. However, after analysis of our pilot results, we stopped the study prematurely because we found no beneficial effects of the surfactant therapy. Despite we displayed a significant correlation between the changes in SpO~2~ and the changes in PaO~2~, the use of changes in SpO~2~ instead of PaO~2~/FiO~2~ for assessment of the efficacy of RM may also be a limitation of our study. Thus, the results of this study as well as the use of derecruitment test and the surfactant therapy in ARDS require further investigation in larger clinical trials.

5. Conclusions {#sec5}
==============

In ALI, the derecruitment test appears to have no predictive value in terms of assessing a potential effect of the alveolar recruitment maneuver. Surfactant therapy combined with RM does not seem to provide any further benefit in comparison with RM and conventional therapy and may even promote lung edema in patients with ALI or ARDS.

###### 

Demographic and clinical characteristics of patients with acute lung injury.

  Patient   Group   Diagnosis      Age, years   Gender   Height, cm   Weight, kg   SAPS II, points   SOFA, points   LIS, points   PaO~2~/FiO~2~, mm Hg   PaCO~2~, mm Hg
  --------- ------- -------------- ------------ -------- ------------ ------------ ----------------- -------------- ------------- ---------------------- ----------------
  1         ST      Pancreatitis   56           m        170          75           30                5              1.70          268                    48.9
  2         ST      Pneumonia      68           m        171          77           48                9              1.50          185                    43.4
  3         ST      Pneumonia      57           m        175          80           46                8              2.25          155                    50.5
  4         CT      Pneumonia      66           m        162          60           44                9              1.75          200                    32.9
  5         CT      Pneumonia      33           m        180          70           37                12             2.75          73                     44.4
  6         CT      Peritonitis    78           f        162          85           66                9              1.75          240                    41.7
  7         ST      Pneumonia      25           m        183          70           25                6              3.67          121                    48.6
  8         CT      Pneumonia      57           m        175          75           46                11             2.00          125                    49.9
  9         CT      Pneumonia      31           f        170          86           22                4              3.25          73                     45.4
  10        ST      Fat embolism   27           m        178          75           28                5              2.75          189                    41.7
  11        ST      Pneumonia      52           m        176          90           31                10             3.25          45                     55.7
  12        CT      Pneumonia      51           m        175          78           45                14             2.50          71                     57.0
  13        CT      Pneumonia      72           m        175          120          54                11             3.00          83                     42.7

Data are presented as absolute values.

ST: surfactant therapy; CT: conventional therapy; LIS: lung injury score; m: male; f: female.

###### 

Changes in hemodynamics, arterial blood gases, and lung mechanics in patients with acute lung injury.

  Parameter                 Group         After the tests   After the FOB   1 hr          2 hrs         4 hrs         8 hrs         16 hrs        24 hrs        32 hrs        48 hrs
  ------------------------- ------------- ----------------- --------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- -------------
  CI, L/min/m^2^            ST            5.03 ± 1.04       4.77 ± 1.16     5.05 ± 1.10   4.79 ± 1.20   4.98 ± 1.15   4.99 ± 1.35   4.89 ± 1.16   4.62 ± 1.03   4.76 ± 0.93   4.35 ± 0.74
  CT                        3.85 ± 1.84   3.90 ± 1.86       3.66 ± 2.09     3.80 ± 1.88   4.20 ± 2.37   3.96 ± 1.82   3.63 ± 1.81   2.75 ± 0.83   3.23 ± 1.10   3.42 ± 1.23   
  GEDVI, mL/m^2^            ST            863 ± 180         690 ± 88        743 ± 206     799 ± 243     797 ± 218     787 ± 142     752 ± 173     743 ± 207     800 ± 275     714 ± 89
  CT                        694 ± 131     675 ± 149         714 ± 172       755 ± 156     749 ± 145     727 ± 111     676 ± 140     694 ± 84      660 ± 108     710 ± 97      
  EVLWI, mL/kg PBW          ST            19 ± 6            23 ± 5          17 ± 6        18 ± 8        17 ± 5        18 ± 4        19 ± 4        18 ± 5^a^     18 ± 3^a^     18 ± 5
  CT                        14 ± 4        15 ± 5            14 ± 6          16 ± 7        14 ± 6        13 ± 6        15 ± 8        11 ± 2        10 ± 3        11 ± 5        
  PaO~2~/FiO~2~, mm Hg      ST            157 ± 62          142 ± 41        131 ± 49      159 ± 58      168 ± 71      147 ± 45      162 ± 126     146 ± 32      219 ± 98      189 ± 41
  CT                        119 ± 40      154 ± 79          139 ± 50        142 ± 46      162 ± 76      168 ± 75      188 ± 89      196 ± 99      205 ± 84      195 ± 107     
  PaCO~2~, mm Hg            ST            56 ± 9^a^         58 ± 9          53 ± 8        51 ± 7        49 ± 11       50 ± 11       54 ± 8^a^     50 ± 15       44 ± 11       47 ± 17
  CT                        45 ± 6        44 ± 11           42 ± 10         44 ± 11       41 ± 11       41 ± 11       40 ± 6        40 ± 3        41 ± 3        43 ± 4        
  EtCO~2~, mm Hg            ST            44 ± 7            45 ± 7          43 ± 7        42 ± 6        40 ± 5        40 ± 6        39 ± 5        40 ± 11       38 ± 9        41 ± 12
  CT                        33 ± 10       37 ± 11           34 ± 11         33 ± 9        32 ± 8        34 ± 8        33 ± 7        31 ± 6        33 ± 6        37 ± 6        
  FiO~2~                    ST            0.58 ± 0.20       0.63 ± 0.25     0.70 ± 0.22   0.63 ± 0.15   0.62 ± 0.13   0.58 ± 0.13   0.64 ± 0.16   0.59 ± 0.08   0.56 ± 0.08   0.50 ± 0.06
  CT                        0.67 ± 0.14   0.70 ± 0.18       0.63 ± 0.11     0.63 ± 0.11   0.62 ± 0.11   0.59 ± 0.11   0.58 ± 0.10   0.54 ± 0.05   0.56 ± 0.08   0.55 ± 0.04   
  PEEP, cm H~2~O            ST            9 ± 6             11 ± 6          12 ± 7        10 ± 6        10 ± 6        10 ± 7        10 ± 5        11 ± 6        11 ± 6        9 ± 4
  CT                        9 ± 4         8 ± 4             9 ± 5           10 ± 5        10 ± 5        9 ± 4         9 ± 4         9 ± 3         9 ± 4         9 ± 4         
  Compliance, mL/cm H~2~O   ST            33 ± 6            33 ± 6          34 ± 5        36 ± 8        37 ± 8        34 ± 8        34 ± 2        31 ± 3        35 ± 3        38 ± 7
  CT                        28 ± 7        32 ± 8            31 ± 6          28 ± 5        28 ± 5        30 ± 7        31 ± 9        30 ± 7        32 ± 9        30 ± 7        

Data are presented as mean ± standard deviation. ^a^intergroup difference (*P* \< 0.05).

After the tests: after both recruitment maneuver and de-recruitment test; ST: surfactant therapy; CT: conventional therapy; FOB: fiberoptic bronchoscopy; CI: cardiac index; GEDVI: global end-diastolic volume index; EVLWI: extravascular lung water index; PBW: predicted body weight; PEEP: positive end-expiratory pressure.
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